Vericel

is a biopharmaceutical firm that develops and commercializes autologous cell therapies for the treatment of severe diseases...
Read more
Vericel President & CEO: Dominick Colangelo

President & CEO

Dominick Colangelo

CEO Approval Rating

89/100

1989

PublicIndependent CompanyNASDAQVCEL

28342836 NAICS listing
Annual Revenue
$237.2M
Employees
300
Funding
$91M

Vericel Competitors

1Cesca
2Osiris Therapeutics
3Athersys
4Alliqua
5Caladrius
6Reapplix
7Amniotechnology
8Capricor
9Mesoblast
10DefiniGEN
See 25+ competitors

Trending Companies